News

Image source: The Motley Fool.

Abbott Laboratories (NYSE: ABT)Q3 2023 Earnings CallOct 18, 2023, 9:00 a.m. ET

Operator

Continue reading

Source Fool.com

Diabetes care and aesthetics. Those are two areas of healthcare that should provide investors with ample growth opportunities in the long run. Two companies that are in solid positions to capitalize

Stocks that are crashing in value can sometimes make for good contrarian investments -- provided that there's a reason to expect a turnaround. But in some situations, investors are better off just

Pharmaceutical giant Pfizer (NYSE: PFE) wasn't looking very tall or strong on the stock exchange Tuesday. The company's share price dipped by nearly 2% over the course of the trading session

Industries with endless demand are great places to find dividend stocks. Healthcare might be the best example of this. No matter how much technology changes, the need to prevent and treat disease

Although sometimes risky and volatile, the biotech industry is an excellent place to find stocks that can generate steady returns for years. That's because these companies tend to offer products

This vaccination season could be a key moment for vaccine makers and investors. That's because it's offering us a first glimpse into the future coronavirus vaccine revenue opportunity. Companies

If you're looking for income-generating investments to fuel your retirement dreams, it's hard to go wrong with dividend-paying stocks in the healthcare sector. After all, people need medical care

Want to invest in stocks that you can buy and forget about? If so, you'll want to consider companies with plenty of long-term growth opportunities and solid financials. Among the best growth

Shares of DexCom (NASDAQ: DXCM) surged higher on Monday, gaining as much as 5.3%. As of 3:04 p.m. ET, the stock was still up 3.6%.

The catalyst that sent the medical device maker higher was bullish

The three most prominent themes in stock investing this year have been artificial intelligence (AI), weight-loss care, and profitability. Companies with strong profitability and/or ties to AI and

Pfizer (NYSE: PFE) and Gilead Sciences (NASDAQ: GILD) are two of the world's largest and most prominent drugmakers, not that this has somehow prevented investors from selling off their shares this

Vertex Pharmaceuticals (NASDAQ: VRTX) is a growing business that generates billions in annual profit and has some incredible opportunities ahead. It's easy to see why investors are bullish on the

What's better than a stock that pays dividends? A stock with growing dividends and a business that's built for long-term success. 

Three Motley Fool contributors identified stocks they think fit the

Shares of UnitedHealth Group (NYSE: UNH) climbed as much as 3.6% early Friday, then settled to trade up around 2.3% as of 2:30 p.m. ET after the the healthcare benefits company announced strong

Image source: The Motley Fool.

UnitedHealth Group (NYSE: UNH)Q3 2023 Earnings CallOct 13, 2023, 8:45 a.m. ET

Operator

Continue reading

Source Fool.com

Shares of Vertex Energy (NASDAQ: VTNR) zoomed on Friday and were trading 10% higher as of 11 a.m. ET after the company projected better-than-expected throughput volumes for its third quarter. The

Large companies often turn to acquisitions to jump-start revenue and earnings growth or to speed up research and development, among other reasons. However, these moves aren't always successful, so

The U.S. Federal Trade Commission (FTC) allowed Amgen's (NASDAQ: AMGN) purchase of Horizon Therapeutics to go through last month and the company announced the closing of the deal in a press release

Shares of Sharecare (NASDAQ: SHCR) were up more than 26% as of 2 p.m. ET on Wednesday after the digital healthcare company said it had received a proposal from a private equity firm to buy the

Shares of several major dialysis stocks plunged on Wednesday after Novo Nordisk (NYSE: NVO) indicated one of its diabetes treatments could also be used to treat chronic kidney disease.

Dialysis

Shares of Fresenius Medical Care (NYSE: FMS) were down more than 18% as of noon ET on Wednesday. The healthcare company's shares are up a little more than 5% so far this year. The drop came because

Stock markets looked poised to continue their winning ways on Wednesday morning, as stock index futures were higher across the board. Investors will get a look today at the latest thought process

Medical device giant Abbott Laboratories (NYSE: ABT) hasn't performed well in the past year. The company has had to deal with several issues that affected its results and its public image, notably